Preliminary analysis suggests this new variant can transmit quicker than the Delta variant and is also far more infectious. Moreover, it’s said, though not confirmed scientifically, the existing vaccines might be less effective against the new variant.
Just when India was recovering from the effects of the second wave, the new variant has added uncertainty. Just this week, the GDP data for the July-September quarter of financial year 2022 showed a growth of 8.4%. This is the fourth consecutive quarter of positive growth after a contraction for two quarters last year.
Analysts are predicting India to hold on to its title of the fastest growing economy in the world until the financial year 2023, given all restrictions are lifted and growth continues to pick up.
But with the new strain emerging, if things get out of control, the government might be forced to bring back the restrictions.
All the core sectors might be affected due to limited activity which in turn will bring down the growth. However, there are few sectors that enjoy relatively higher resistance to another lockdown.
One of them is the healthcare space.
The pandemic has acted as a catalyst of positive change to shape the healthcare sector across the world.
Here are few stocks to watch out for in the healthcare and diagnostic space in India as the new ‘variant of concern’ spreads.
Cipla is a…